COVVI Robotics To Officially Launch At ICRA 2023
At the end of May, the COVVI team will travel down to London to exhibit at ICRA 2023, the IEEE Robotics and Automation Society’s flagship conference. This global event has been taking place since 1984 and shares the very latest research and findings in robotics and automation. This year, the conference focuses on “embracing the future: making robots for humans”.
COVVI Robotics is a project the team has been working on since 2021 and our visionary engineers have been developing a ground-breaking bionic hand for use in the nuclear energy sector, to reduce injuries caused during nuclear decommissioning. And as a part of this venture, we formed a strategic partnership with Atkins Plc and their parent company SNS Lavalin Group, to develop COVVI’s multi-articulated hand for the robotics market.
Currently used on those with upper limb deficiencies, a new iteration of COVVI’s bionic hand will be utilised as a part of a robotic solution which aims to eliminate the need for operators to physically put their hands into gloveboxes to treat nuclear waste. This innovative technology will reduce the risks of on-site accidents and therefore also help to prevent nuclear plants from closure when accident investigations need to take place.
Simon Pollard, Group CEO at COVVI said; “The robotics market continues to develop at pace as it becomes more affordable, scalable, and customisable. We are excited about the opportunity to implement new and innovative solutions that will help support repetitive tasks in hazardous environments within the nuclear industry.”
A separate website for COVVI Robotics will also be launched to provide information specific to this new device and its potential applications. We are incredibly proud of the developments we’ve made during this venture, and we’re excited to finally be sharing all of our hard work. We truly believe that this partnership will help us to deliver a world-leading robotic hand to as many companies and industries as possible.